Trp53-KO/Kras-G12D


Strain Information

Validation Data

image.png

Fig1. Genotype identification of Trp53-KO/Kras-G12D cell line

image.png

Fig2. Tumor growth curve in Trp53-KO/Kras-G12D syngeneic model (n=10)

image.png

Fig3. Body weight change of Trp53-KO/Kras-G12D syngeneic model (n=10)


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more